Prostate Cancer
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directions.
September 5, 2024
A Multi-Institutional Study of MR/US Fusion Guided Nanoparticle Directed Focal Therapy for Prostate Ablation.
September 5, 2024
Talazoparib for the treatment of prostate cancer.
September 5, 2024
PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer.
September 5, 2024
Pelvic Lymph Node Dissection: A Comparison Among Extraperitoneal Single-port and Transperitoneal Multiport Radical Prostatectomy-A Single-center Experience.
September 5, 2024
Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysis.
September 4, 2024
Androgen production, uptake, and conversion (APUC) genes define prostate cancer patients with distinct clinical outcomes.
September 4, 2024
Statin concentration in prostatic tissue is subtype- and dose-dependent.
September 4, 2024
Identifying Barriers to Timely Follow-up After Elevated PSA Screening: A Retrospective Analysis of a Large Healthcare System.
September 4, 2024
MRI-based PI-RADS score predicts ISUP upgrading and adverse pathology at radical prostatectomy in men with biopsy ISUP 1 prostate cancer.
September 3, 2024
Clinical implementation of real time motion management for prostate SBRT: A radiation therapist's perspective.
September 3, 2024
Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound.
September 3, 2024